Using big data to tackle HIV, Hepatitis C, and opioid issues in the South
Harnessing big data to arrest the HIV/HCV/opioid syndemic in the rural and urban South
This study is looking at how HIV, Hepatitis C, and opioid use are linked in different communities in the Southern U.S., and it aims to find ways to help those most at risk by improving prevention and healthcare resources.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-11051835 on NIH RePORTER |
What this research studies
This research focuses on understanding and addressing the interconnected epidemics of HIV, Hepatitis C (HCV), and opioid use in rural and urban areas of the Southern United States. By analyzing large datasets, the project aims to identify vulnerable populations and develop targeted interventions to reduce the spread of these conditions. The approach includes monitoring drug overdose rates and assessing the impact of shared injection practices on HIV transmission. Patients may benefit from improved prevention strategies and healthcare resources as a result of this research.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals living in the Southern U.S. who are at risk for or currently affected by HIV, Hepatitis C, or opioid use disorders.
Not a fit: Patients who do not reside in the Southern U.S. or who are not affected by HIV, Hepatitis C, or opioid use may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective strategies for preventing and treating HIV and Hepatitis C in high-risk populations.
How similar studies have performed: Other research has shown success in using big data to inform public health interventions for similar syndemics, indicating that this approach is promising.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Rebeiro, Peter F — Vanderbilt University Medical Center
- Study coordinator: Rebeiro, Peter F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.